Optimizing Outpatient Pain Management After Thyroid and Parathyroid Surgery: A Two-Institution Experience

  • Irene Lou
  • Todd B. Chennell
  • Sarah C. Schaefer
  • Herbert Chen
  • Rebecca S. Sippel
  • Courtney Balentine
  • David F. Schneider
  • Jacob Moalem
Endocrine Tumors

DOI: 10.1245/s10434-017-5781-y

Cite this article as:
Lou, I., Chennell, T.B., Schaefer, S.C. et al. Ann Surg Oncol (2017). doi:10.1245/s10434-017-5781-y
  • 31 Downloads

Abstract

Background

Thyroidectomy and parathyroidectomy are the most commonly performed endocrine operations, and are increasingly being completed on a same-day basis; however, few data exist regarding the outpatient postoperative pain requirement of these patients. We aimed to describe the outpatient narcotic medication needs for patients undergoing thyroid and parathyroid surgery, and to identify predictors of higher requirement.

Method

We examined patients undergoing thyroid and parathyroid surgery at two large academic institutions from 1 January–30 May 2014. Prospective data were collected on pain scores and the oral morphine equivalents (OMEQs) taken by these patients by their postoperative visit.

Results

Overall, 313 adult patients underwent thyroidectomy or parathyroidectomy during the study period; 83% of patients took ten or fewer OMEQs, and 93% took 20 or fewer OMEQs. Patients who took more than ten OMEQs were younger (p < 0.001) and reported significantly higher overall mean pain scores at their postoperative visit (p < 0.001) than patients who took fewer than ten OMEQs. A multivariate model was constructed on pre- and intraoperative factors that may predict use of more than ten OMEQs postoperatively. Age <45 years (p = 0.002), previous narcotic use (p = 0.037), and whether parathyroid or thyroid surgery was performed (p = 0.003) independently predicted the use of more than ten OMEQs after surgery. A subgroup analysis was then performed on thyroidectomy-only patients.

Conclusion

Overall, 93% of patients undergoing thyroidectomy and parathyroidectomy require 20 or fewer OMEQs by their postoperative visit. We therefore recommend these patients be discharged with 20 OMEQs, both to minimize waste and increase patient safety.

Copyright information

© Society of Surgical Oncology 2017

Authors and Affiliations

  • Irene Lou
    • 1
    • 2
  • Todd B. Chennell
    • 2
  • Sarah C. Schaefer
    • 1
  • Herbert Chen
    • 1
    • 3
  • Rebecca S. Sippel
    • 1
  • Courtney Balentine
    • 1
    • 3
  • David F. Schneider
    • 1
  • Jacob Moalem
    • 2
  1. 1.Section of Endocrine Surgery, Department of SurgeryUniversity of WisconsinMadisonUSA
  2. 2.Department of SurgeryUniversity of RochesterRochesterUSA
  3. 3.Department of SurgeryUniversity of Alabama at BirminghamBirminghamUSA